Ads
related to: moderna vaccine
Search results
The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why.
Barrons.com· 2 days agoThe stock was down 5.5% Wednesday morning, bringing the stocks losses to 13% since the market closed...
Moderna (NASDAQ:MRNA) Stock Price Down 6.2%
ETF DAILY NEWS· 1 day agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) shares fell 6.2% during trading on Tuesday . The company traded as low as $156.15 and last traded at $156.26. 873,085 shares ...
Insider Selling: Moderna, Inc. (NASDAQ:MRNA) Insider Sells 1,296 Shares of Stock
ETF DAILY NEWS· 1 day agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) insider Shannon Thyme Klinger sold 1,296 shares of the company’s stock in a transaction dated Tuesday, May 28th. Following the ...
US poised to invest millions in mRNA bird flu vaccine amid H5N1 scare
The Telegraph via Yahoo News· 19 hours agoThe US government is poised to announce a multimillion-dollar investment in mRNA vaccines for H5N1...
Thousands of cancer patients to trial personalised vaccines
BBC via Yahoo News· 10 hours agoThat jab was created by Moderna, and used the same technology as in their Covid jabs. Moderna and...
The US is close to an agreement on funding for moderna bird flu vaccine trials, the FT reports
Weston Forum· 1 day agoThe Financial Times reported Thursday that the U.S. government is nearing a deal to fund late-stage...
Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
Zacks via Yahoo Finance· 3 days agoBeing one of the handful of makers of a COVID-19 vaccine, Moderna reaped the benefits of the...
Moderna Stock Is Having Another Very Bad Day. Here’s Why.
Barrons.com· 2 days agoThe stock’s drop comes as Moderna awaits important developments involving its experimental cancer...
Should You Buy This Stock After a Regulatory Setback?
The Motley Fool via AOL· 5 days agoIts late-stage pipeline is exciting. The company is running phase 3 studies for a combination...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 7 days agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...
